Hraba T, Dolezal J
Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
Int J Immunopharmacol. 1995 Jun;17(6):523-6. doi: 10.1016/0192-0561(95)00033-x.
The previously developed mathematical model simulates the CD4+ lymphocyte dynamics in HIV infection very well. As the number of these cells is a good indicator of the infection progression, it was used to evaluate the effectiveness of different therapeutic interventions. For chemotherapy simulation, both permanent and temporary zinovudine (AZT) administration were considered and the induced return of the CD4+ lymphocyte counts was analysed. Similar analysis was performed for active and passive immunotherapy. The model offers also the possibility of stimulating the CD4+ dynamics after depletion of CD8+ lymphocytes by antibodies. Even one simulated administration of anti-CD8 antibodies increases the CD4+ lymphocyte counts and prolongs the survival of the patient. However, if cells involved in protective immunity are assumed to belong to the CD8+ category, anti-CD8 antibodies accelerate the decrease of CD4- cells and thus shorten the patient's survival.
先前开发的数学模型能很好地模拟HIV感染中CD4+淋巴细胞的动态变化。由于这些细胞的数量是感染进展的良好指标,它被用于评估不同治疗干预措施的有效性。对于化疗模拟,考虑了长期和短期给予齐多夫定(AZT),并分析了诱导的CD4+淋巴细胞计数的恢复情况。对主动和被动免疫疗法进行了类似分析。该模型还提供了在通过抗体耗尽CD8+淋巴细胞后刺激CD4+动态变化的可能性。即使模拟一次给予抗CD8抗体也会增加CD4+淋巴细胞计数并延长患者的生存期。然而,如果假设参与保护性免疫的细胞属于CD8+类别,抗CD8抗体则会加速CD4+细胞的减少,从而缩短患者的生存期。